Bacteria‐Mediated Tumor‐Targeting Delivery of Multienzyme‐Mimicking Covalent Organic Frameworks Promoting Pyroptosis for Combinatorial Sono‐Catalytic Immunotherapy
Pyroptosis, an inflammatory cell death, has attracted great attention for potentiating a strong immune response against tumor cells. However, developing powerful pyroptosis inducers and then activating specific pyroptosis still remains challenging. Herein, a PEG-CuP-COF@∆St nanosystem is rationally designed, consisting of PEG-CuP-COF nanozyme pyroptosis inducers and tumor-targeting bacteria of the Salmonella Typhimurium strain VNP20009 (ΔSt), with an affinity for the tumor hypoxic microenvironment. The PEG-CuP-COF nanozymes possessed excellent sonodynamic performance and multienzyme-mimicking activities to generate reactive oxygen species (ROS) and then induce potent pyroptosis. The superoxide dismutase- and peroxidase-mimicking activities of PEG-CuP-COF catalytically produced hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) and hydroxyl radicals (•OH) which have important value in triggering acute inflammatory responses and pyroptosis. Moreover, PEG-CuP-COF showed outstanding glutathione peroxidase-mimicking activities, impairing the antioxidant defense in tumor cells and enhancing sonodynamic efficiency by making them more vulnerable to ROS-induced damage. During in vivo studies, PEG-CuP-COF@∆St nanosystem with its self-driven property exhibited impressive tumor-targeting capability and activated Caspase-3/gasdermin E-dependent pyroptosis to inhibit tumor growth. More importantly, it induced a powerful immune memory effect to prevent bone metastasis. In summary, this study introduces an innovative approach for combinatorial sono-catalytic immunotherapy using bacteria-mediated tumor-targeting delivery of nanozymes as specific pyroptosis inducers.
Authors
- Yitong Li (ORCID: https://orcid.org/0009-0002-6116-0609)
- Shaoyue Li (ORCID: https://orcid.org/0009-0006-3180-6607)
- Hui Liu
- Haohao Yin (ORCID: https://orcid.org/0000-0002-5404-7336)
- Beibei Ye
- Li‐Hua Xiang
- Dou Du (ORCID: https://orcid.org/0000-0001-8245-6295)
- Hui Shi (ORCID: https://orcid.org/0000-0002-0104-8212)
- Shen Zhang (ORCID: https://orcid.org/0009-0008-9222-4437)
- Yunyun Liu (ORCID: https://orcid.org/0000-0002-5553-1672)
- Bangguo Zhou
- Yifeng Zhang (ORCID: https://orcid.org/0000-0001-6078-6015)
- Ying Zhang (ORCID: https://orcid.org/0000-0001-5476-1524)
Institutions
- Tongji University (CN)
- Fudan University (CN)
- Zhongshan Hospital (CN)
- Shanghai Tenth People's Hospital (CN)
Publication Details
- Journal
- Advanced Science
- Published
- 2024-11-04
- DOI
- https://doi.org/10.1002/advs.202407133
- Citations
- 16
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 2.95
Funders
- National Natural Science Foundation of China